Clinical implications of comprehensive molecular testing

Published Alicia Mew on Tue, 10/03/2023 - 12:11

VCCC Alliance Precision Oncology Forum

Clinical implications of comprehensive molecular testing

18 Aug 2023

The VCCC PRECISION study has aided the establishment of an optimised local genomic testing infrastructure and assesses clinical utility in patients with advanced solid tumours.

In this Precision Oncology Forum, Dr Sathya Manoharan will provide the latest findings from VCCC PRECISION. Dr Stephen Luen will also provide updates on the IMPARP-HRD study.

Aim: To discuss the clinical implications of comprehensive molecular testing in patients with advanced solid tumours using the VCCC PRECISION study.

Learning objective: In this session, you will gain a greater insight into the latest findings from VCCC PRECISION and the IMPARP-HRD study

Content warning: The VCCC Alliance Precision Oncology Forum is aimed primarily at a clinical audience and features open discussion about real cases and patients. While these cases are de-identified, the imagery, content and discussion can be graphic.

Chair

Dr Stephen Luen 
Medical Oncologist at Peter MacCallum Cancer Centre

Presenter 

Dr Sathya Manoharan
Early Drug Development Fellow, Peter MacCallum Cancer Centre

Course Details

double_helix
Course type
Webinars
Duration
60 mins
Price
$0.00
Curriculum Area
Research (incl. Clinical Trials)
Speciality
Senior researcher / scientist
Early to mid career researcher
Precision medicine
Precision oncology

This course is brought to you by

Alliance members